Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
-99K
-
Total reported value, excl. options
-
$175M
-
Value change
-
-$218K
-
Put/Call ratio
-
1.44
-
Number of buys
-
52
-
Number of sells
-
-26
-
Price
-
$7.71
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2023
99 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q1 2023.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 55.2M outstanding shares and own 41.05% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.85M shares), ARMISTICE CAPITAL, LLC (3.52M shares), TRV GP III, LLC (3.19M shares), VANGUARD GROUP INC (1.96M shares), MILLENNIUM MANAGEMENT LLC (1.16M shares), Erste Asset Management GmbH (1.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (901K shares), BlackRock Inc. (824K shares), FARALLON CAPITAL MANAGEMENT LLC (797K shares), and ACADIAN ASSET MANAGEMENT LLC (742K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.